News

ACP Elevates Tirzepatide to First-Line Obesity Treatment in New Guideline
The American College of Physicians now recommends tirzepatide as first-line obesity treatment, reshaping prescribing practices and insurance coverage for the dual GLP-1/GIP agonist. Read more...